AKT3 and breast carcinoma: Research by Ehud Wainstein et al. indicated that in breast cancer cells, AKT3 is constitutively phosphorylated at the nuclear membrane, facilitating the continuous phosphorylation of tuberous sclerosis complex 2 (TSC2) at this site (Wainstein et al., 2022).